DrugPatentWatch Database Preview
Patent: 4,557,934
» See Plans and Pricing
Summary for Patent: 4,557,934
| Title: | Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one |
| Abstract: | Improved topical pharmaceutical compositions containing a pharmaceutically-active agent and the penetration enhancing agent 1-dodecylazacycloheptan-2-one are disclosed. This agent is used at selected levels in combination with certain C.sub.3 -C.sub.4 diols or a 1-substituted azacycloalkyl-2-one. This composition provides marked transepidermal and percutaneous delivery of the selected pharmaceutically-active agent. A method of treating certain pathologies and conditions responsive to the selected active, systemically or locally, is also disclosed. |
| Inventor(s): | Cooper; Eugene R. (Cincinnati, OH) |
| Assignee: | The Procter & Gamble Company (Cincinnati, OH) |
| Application Number: | 06/506,275 |
| Patent Claims: | see list of patent claims |
Details for Patent 4,557,934
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merck | ELSPAR | asparaginase | VIAL | 101063 | 001 | 1978-01-10 | Start Trial | The Procter & Gamble Company (Cincinnati, OH) | 2039-03-29 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 4,557,934
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Philippines | 20235 | Start Trial |
| New Zealand | 208597 | Start Trial |
| Japan | S6036422 | Start Trial |
| Spain | 533579 | Start Trial |
| Spain | 8608875 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
